Cheryl W. Grise - 11 Mar 2025 Form 4 Insider Report for METLIFE INC (MET)

Role
Director
Signature
/s/ Taylor Jansen, Authorized Signer
Issuer symbol
MET
Transactions as of
11 Mar 2025
Net transactions value
+$44,873
Form type
4
Filing time
13 Mar 2025, 16:18:54 UTC
Previous filing
06 Jan 2025
Next filing
03 Apr 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction MET Common Stock Award $44,873 +572 +0.66% $78.45 87,649 11 Mar 2025 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Imputed reinvestment of dividends on deferred shares pursuant to the MetLife Deferred Compensation Plan for Non-Management Directors. Deferred shares represent shares of MetLife, Inc. common stock that have become payable, but receipt of which the director has deferred.